Company Search:
Advanced Search
Sponsored Links
Medivir AB Company Snapshot
Medivir AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medivir AB with three other companies in this sector in Sweden: Sprint Bioscience AB (2017 sales of 23.97 million Swedish Kronor [US$2.93 million] ), Saniona AB (20.69 million Swedish Kronor [US$2.53 million] ), and Bioinvent International AB (45.01 million Swedish Kronor [US$5.50 million] ).

Sales Analysis. Medivir AB reported sales of SEK 36.60 million (US$4.47 million) for the year ending December of 2017. This represents a sharp decrease of 60.7% versus 2016, when the company's sales were SEK 93.04 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medivir AB
  Stock Performance Chart for Medivir AB
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 38.25
(Figures in Swedish Kronor)
1 Week -3.9%   13 Weeks -1.7%  
4 Weeks -23.3%   52 Weeks -46.5%  
Medivir AB Key Data:
  Ticker: MVIR-B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 36,600,000
(Year Ending Jan 2018).
Employees: 117
  Currency: Swedish Kronor Market Cap: 776,781,000
  Fiscal Yr Ends: December Shares Outstanding: 20,308,000
  Share Type: B Fri Aktie Closely Held Shares: 2,461,975
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.